Bortezomib-induced acute pancreatitis in a patient with multiple myeloma

Bortezomib, a proteasome inhibitor, has demonstrated remarkable efficacy in multiple myeloma (MM) [1,2], and its use as frontline treatment in patients with MM is now recommended by the National Co...